Post-pandemic Era Global Interventional Cardiovascular Devices Market Segment Research Report 2024
Summary
The global economy is expected to expand 5.6% in 2021，global recovery is strong but uneven as many emerging market and developing economies continue to struggle with the COVID-19 pandemic, the world is unlikely to ever reach global herd immunity. However, the recovery in many countries is being held back by a resurgence of COVID-19 cases and lagging vaccination progress, as well as the withdrawal of policy support in some instances.
The annual U.S. economic growth rate slipped to -3.5% in 2020, but grew at a yearly pace of more than 6% in the previous two quarters of 2021. The economy of continental Europe bounced back in the second quarter after having contracted in both the fourth quarter of 2020 and the first quarter of 2021, as the vaccinations accelerated, and governments eased restrictions. Among major economies, the annualized growth rate was 6.1% in Germany, 3.6% in France, 11.2% in Italy, and 11.7% in Spain. The especially rapid growth in Spain and Italy was attributed to a surge in consumer spending, likely the result of an easing of economic restrictions.
Regional Economic ProspectsGrowth in the East Asia and Pacific is projected to accelerate by 7.7% in 2021, Central Asia is forecast to grow by 3.9% this year, economic activity in the Middle East and North Africa is forecast to advance by 2.4%, South Asia is projected to expand by 6.8%.
The global Interventional Cardiovascular Devices market size was USD XX billion in 2021. It is likely to progress at a CAGR of XX% during the forecast period of 2022-2027, according to MR Accuracy Reports analysis, The segment in Interventional Cardiovascular Devices market is estimated to reach a market value of USD XX billion by 2021 from an initial market value of USD XX billion in 2021. China market value in 2021 is about USD XX billion, and China Interventional Cardiovascular Devices production is XX (K Units). US market value in 2021 is about USD XX billion, and US Interventional Cardiovascular Devices production is XX (K Units). Europe market value in 2021 is about USD XX billion, and Europe Interventional Cardiovascular Devices production is XX (K Units).
Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of Interventional Cardiovascular Devices Market by MR Accuracy Reports Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Interventional Cardiovascular Devices Market?
GE Healthcare
Boston Scientific
Johnson & Johnson
Medtronic
Philips
Abbott Laboratories
Terumo
Argon Medical Devices
Volcano Therapeutics
Argon Medical
Spectranetics
Angio Dynamics
AccessClosure
Merit Medical Systems
B. Braun
C. R. Bard
Marine Polymer Technologies
Cordis
Major Type of Interventional Cardiovascular Devices Covered in MR Accuracy Reports report
Imaging System
Catheter
PTCA Balloon
Stent
PTCA Guidewire
Other
Application Segments Covered in MR Accuracy Reports Market
Hospitals
Clinics
Other
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Content
Table of Contents
Global Interventional Cardiovascular Devices Market Segment Research Report 2021
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Interventional Cardiovascular Devices Market by Value
2.2.1 Global Interventional Cardiovascular Devices Revenue by Type
2.2.2 Global Interventional Cardiovascular Devices Market by Value (%)
2.3 Global Interventional Cardiovascular Devices Market by Production
2.3.1 Global Interventional Cardiovascular Devices Production by Type
2.3.2 Global Interventional Cardiovascular Devices Market by Production (%)
3. The Major Driver of Interventional Cardiovascular Devices Industry
3.1 Historical & Forecast Global Interventional Cardiovascular Devices Demand
3.2 Largest Application for Interventional Cardiovascular Devices (2017-2027)
3.3 The Major Downstream Company in China Market 2021
4. Global and Regional Interventional Cardiovascular Devices Market
4.1 Regional Market Size in Terms of Production & Demand (2021)
4.2 Regional Market Share in Terms of Revenue (2019-2027)
4.3 Concentration Ratio (CR5& CR10) of Interventional Cardiovascular Devices Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Interventional Cardiovascular Devices Production, Demand (2017-2027)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Demand Breakdown by Type
5.3 Current and Estimated Demand Breakdown by Application
5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
6. Europe Interventional Cardiovascular Devices Production, Demand (2017-2027)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Demand Breakdown by Type
6.3 Current and Estimated Demand Breakdown by Application
6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
7. China Interventional Cardiovascular Devices Production, Demand (2017-2027)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Demand Breakdown by Type
7.3 Current and Estimated Demand Breakdown by Application
7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
8. Japan Interventional Cardiovascular Devices Production, Demand (2017-2027)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Demand Breakdown by Type
8.3 Current and Estimated Demand Breakdown by Application
8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
9. India Interventional Cardiovascular Devices Production, Demand (2017-2027)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Demand Breakdown by Type
9.3 Current and Estimated Demand Breakdown by Application
9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
10. Korea Interventional Cardiovascular Devices Production, Demand (2017-2027)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Demand Breakdown by Type
10.3 Current and Estimated Demand Breakdown by Application
10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
11. Southeast Asia Interventional Cardiovascular Devices Production, Demand (2017-2027)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Demand Breakdown by Type
11.3 Current and Estimated Demand Breakdown by Application
11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)
12. Global Interventional Cardiovascular Devices Average Price Trend
12.1 Market Price for Each Type of Interventional Cardiovascular Devices in US (2017-2021)
12.2 Market Price for Each Type of Interventional Cardiovascular Devices in Europe (2017-2021)
12.3 Market Price for Each Type of Interventional Cardiovascular Devices in China (2017-2021)
12.4 Market Price for Each Type of Interventional Cardiovascular Devices in Japan (2017-2021)
12.5 Market Price for Each Type of Interventional Cardiovascular Devices in India (2017-2021)
12.6 Market Price for Each Type of Interventional Cardiovascular Devices in Korea (2017-2021)
12.7 Market Price for Each Type of Interventional Cardiovascular Devices in Southeast Asia (2017-2021)
13. Industrial Chain (Impact of COVID-19)
13.1 Interventional Cardiovascular Devices Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Technology Trends of Interventional Cardiovascular Devices
14. Interventional Cardiovascular Devices Competitive Landscape
14.1 GE Healthcare
14.1.1 GE Healthcare Company Profiles
14.1.2 GE Healthcare Product Introduction
14.1.3 GE Healthcare Interventional Cardiovascular Devices Sales, Revenue (2017-2021)
14.1.4 Strategic initiatives
14.2 Boston Scientific
14.2.1 Boston Scientific Company Profiles
14.2.2 Boston Scientific Product Introduction
14.2.3 Boston Scientific Interventional Cardiovascular Devices Sales, Revenue (2017-2021)
14.2.4 Strategic initiatives
14.3 Johnson & Johnson
14.3.1 Johnson & Johnson Company Profiles
14.3.2 Johnson & Johnson Product Introduction
14.3.3 Johnson & Johnson Interventional Cardiovascular Devices Sales, Revenue (2017-2021)
14.3.4 Strategic initiatives
14.4 Medtronic
14.4.1 Medtronic Company Profiles
14.4.2 Medtronic Product Introduction
14.4.3 Medtronic Interventional Cardiovascular Devices Sales, Revenue (2017-2021)
14.4.4 Strategic initiatives
14.5 Philips
14.5.1 Philips Company Profiles
14.5.2 Philips Product Introduction
14.5.3 Philips Interventional Cardiovascular Devices Sales, Revenue (2017-2021)
14.5.4 Strategic initiatives
14.6 Abbott Laboratories
14.6.1 Abbott Laboratories Company Profiles
14.6.2 Abbott Laboratories Product Introduction
14.6.3 Abbott Laboratories Interventional Cardiovascular Devices Sales, Revenue (2017-2021)
14.6.4 Strategic initiatives
14.7 Terumo
14.7.1 Terumo Company Profiles
14.7.2 Terumo Product Introduction
14.7.3 Terumo Interventional Cardiovascular Devices Sales, Revenue (2017-2021)
14.7.4 Strategic initiatives
14.8 Argon Medical Devices
14.8.1 Argon Medical Devices Company Profiles
14.8.2 Argon Medical Devices Product Introduction
14.8.3 Argon Medical Devices Interventional Cardiovascular Devices Sales, Revenue (2017-2021)
14.8.4 Strategic initiatives
14.9 Volcano Therapeutics
14.9.1 Volcano Therapeutics Company Profiles
14.9.2 Volcano Therapeutics Product Introduction
14.9.3 Volcano Therapeutics Interventional Cardiovascular Devices Sales, Revenue (2017-2021)
14.9.4 Strategic initiatives
14.10 Argon Medical
14.10.1 Argon Medical Company Profiles
14.10.2 Argon Medical Product Introduction
14.10.3 Argon Medical Interventional Cardiovascular Devices Sales, Revenue (2017-2021)
14.10.4 Strategic initiatives
14.11 Spectranetics
14.12 Angio Dynamics
14.13 AccessClosure
14.14 Merit Medical Systems
14.15 B. Braun
14.16 C. R. Bard
14.17 Marine Polymer Technologies
14.18 Cordis
15. Conclusion
List of Figure
List of Tables and Figures
Figure 1. Total Demand by Application of Interventional Cardiovascular Devices Industry (Volume)
Figure 2. Interventional Cardiovascular Devices Production & Demand by Regions in 2021
Figure 3. Regional Market Share in Terms of Revenue (2021&2027)
Figure 4. The Top 10 and 5 Players Market Share by Interventional Cardiovascular Devices Revenue in 2021
Figure 5. US Interventional Cardiovascular Devices Production, Demand (2017-2027)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Interventional Cardiovascular Devices Production, Demand (2017-2027)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Interventional Cardiovascular Devices Production, Demand (2017-2027)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Interventional Cardiovascular Devices Production, Demand (2017-2027)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Interventional Cardiovascular Devices Production, Demand (2017-2027)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Interventional Cardiovascular Devices Production, Demand (2017-2027)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Interventional Cardiovascular Devices Production, Demand (2017-2027)
Figure 43. Current and Estimated Production Breakdown by Type (2017-2027)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Interventional Cardiovascular Devices Revenue, by Type (Million USD) (2017-2027)
Table 4. Interventional Cardiovascular Devices Production, by Type (K Unit) (2017-2027)
Table 5. Interventional Cardiovascular Devices Demand (K Unit) by Application (2017-2027)
Table 6. Interventional Cardiovascular Devices Demand (Million USD) by Application (2017-2027)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2021)
Table 9. Regional Market Share in Terms of Revenue (2021&2027)
Table 10. Ranking of Global Top Interventional Cardiovascular Devices Companies by Revenue, Concentration Ratio in 2021
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Interventional Cardiovascular Devices Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 13. Current and Estimated Production Breakdown by Type (2017-2027)
Table 14. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 15. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Interventional Cardiovascular Devices Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 19. Current and Estimated Production Breakdown by Type (2017-2027)
Table 20. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 21. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Interventional Cardiovascular Devices Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Interventional Cardiovascular Devices Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 30. Current and Estimated Production Breakdown by Type (2017-2027)
Table 31. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 32. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Interventional Cardiovascular Devices Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 36. Current and Estimated Production Breakdown by Type (2017-2027)
Table 37. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 38. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Interventional Cardiovascular Devices Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 42. Current and Estimated Production Breakdown by Type (2017-2027)
Table 43. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 44. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Interventional Cardiovascular Devices Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 48. Table Current and Estimated Demand Breakdown by Type (2017-2027)
Table 49. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Interventional Cardiovascular Devices in US (2017-2021)
Table 53. Market Price (USD/Unit) for Each Type of Interventional Cardiovascular Devices in Europe (2017-2021)
Table 54. Market Price (USD/Unit) for Each Type of Interventional Cardiovascular Devices in China (2017-2021)
Table 55. Market Price (USD/Unit) for Each Type of Interventional Cardiovascular Devices in Japan (2017-2021)
Table 56. Market Price (USD/Unit) for Each Type of Interventional Cardiovascular Devices in India (2017-2021)
Table 57. Market Price (USD/Unit) for Each Type of Interventional Cardiovascular Devices in Korea (2017-2021)
Table 58. Market Price (USD/Unit) for Each Type of Interventional Cardiovascular Devices in Southeast Asia (2017-2021)
Table 59. Key Downstream Customer in Each Application Field
Table 60. GE Healthcare Profiles
Table 61. GE Healthcare Interventional Cardiovascular Devices Product Introduction
Table 62. GE Healthcare Interventional Cardiovascular Devices Sales (Unit), Revenue (Million USD) (2017-2021)
Table 63. GE Healthcare Strategic initiatives
Table 64. Boston Scientific Profiles
Table 65. Boston Scientific Interventional Cardiovascular Devices Product Introduction
Table 66. Boston Scientific Interventional Cardiovascular Devices Sales (Unit), Revenue (Million USD) (2017-2021)
Table 67. Boston Scientific Strategic initiatives
Table 68. Johnson & Johnson Profiles
Table 69. Johnson & Johnson Interventional Cardiovascular Devices Product Introduction
Table 70. Johnson & Johnson Interventional Cardiovascular Devices Sales (Unit), Revenue (Million USD) (2017-2021)
Table 71. Johnson & Johnson Strategic initiatives
Table 72. Medtronic Profiles
Table 73. Medtronic Interventional Cardiovascular Devices Product Introduction
Table 74. Medtronic Interventional Cardiovascular Devices Sales (Unit), Revenue (Million USD) (2017-2021)
Table 75. Medtronic Strategic initiatives
Table 76. Philips Profiles
Table 77. Philips Interventional Cardiovascular Devices Product Introduction
Table 78. Philips Interventional Cardiovascular Devices Sales (Unit), Revenue (Million USD) (2017-2021)
Table 79. Philips Strategic initiatives
Table 80. Abbott Laboratories Profiles
Table 81. Abbott Laboratories Interventional Cardiovascular Devices Product Introduction
Table 82. Abbott Laboratories Interventional Cardiovascular Devices Sales (Unit), Revenue (Million USD) (2017-2021)
Table 83. Abbott Laboratories Strategic initiatives
Table 84. Terumo Profiles
Table 85. Terumo Interventional Cardiovascular Devices Product Introduction
Table 86. Terumo Interventional Cardiovascular Devices Sales (Unit), Revenue (Million USD) (2017-2021)
Table 87. Terumo Strategic initiatives
Table 88. Argon Medical Devices Profiles
Table 89. Argon Medical Devices Interventional Cardiovascular Devices Product Introduction
Table 90. Argon Medical Devices Interventional Cardiovascular Devices Sales (Unit), Revenue (Million USD) (2017-2021)
Table 91. Argon Medical Devices Strategic initiatives
Table 92. Volcano Therapeutics Profiles
Table 93. Volcano Therapeutics Interventional Cardiovascular Devices Product Introduction
Table 94. Volcano Therapeutics Interventional Cardiovascular Devices Sales (Unit), Revenue (Million USD) (2017-2021)
Table 95. Volcano Therapeutics Strategic initiatives
Table 97. Argon Medical Profiles
Table 98. Argon Medical Interventional Cardiovascular Devices Product Introduction
Table 99. Argon Medical Interventional Cardiovascular Devices Sales (Unit), Revenue (Million USD) (2017-2021)
Table 100. Argon Medical Strategic initiatives
Table 101. Spectranetics Profiles
Table 102. Spectranetics Interventional Cardiovascular Devices Product Introduction
Table 103. Spectranetics Interventional Cardiovascular Devices Sales (Unit), Revenue (Million USD) (2017-2021)
Table 104. Spectranetics Strategic initiatives
Table 105. Angio Dynamics Profiles
Table 106. Angio Dynamics Interventional Cardiovascular Devices Product Introduction
Table 107. Angio Dynamics Interventional Cardiovascular Devices Sales (Unit), Revenue (Million USD) (2017-2021)
Table 108. Angio Dynamics Strategic initiatives
Table 109. AccessClosure Profiles
Table 110. AccessClosure Interventional Cardiovascular Devices Product Introduction
Table 111. AccessClosure Interventional Cardiovascular Devices Sales (Unit), Revenue (Million USD) (2017-2021)
Table 112. AccessClosure Strategic initiatives
Table 113. Merit Medical Systems Profiles
Table 114. Merit Medical Systems Interventional Cardiovascular Devices Product Introduction
Table 115. Merit Medical Systems Interventional Cardiovascular Devices Sales (Unit), Revenue (Million USD) (2017-2021)
Table 116. Merit Medical Systems Strategic initiatives
Table 117. B. Braun Profiles
Table 118. B. Braun Interventional Cardiovascular Devices Product Introduction
Table 119. B. Braun Interventional Cardiovascular Devices Sales (Unit), Revenue (Million USD) (2017-2021)
Table 120. B. Braun Strategic initiatives
Table 121. C. R. Bard Profiles
Table 122. C. R. Bard Interventional Cardiovascular Devices Product Introduction
Table 123. C. R. Bard Interventional Cardiovascular Devices Sales (Unit), Revenue (Million USD) (2017-2021)
Table 124. C. R. Bard Strategic initiatives
Table 125. Marine Polymer Technologies Profiles
Table 126. Marine Polymer Technologies Interventional Cardiovascular Devices Product Introduction
Table 127. Marine Polymer Technologies Interventional Cardiovascular Devices Sales (Unit), Revenue (Million USD) (2017-2021)
Table 128. Marine Polymer Technologies Strategic initiatives
Table 129. Cordis Profiles
Table 130. Cordis Interventional Cardiovascular Devices Product Introduction
Table 131. Cordis Interventional Cardiovascular Devices Sales (Unit), Revenue (Million USD) (2017-2021)
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices